Nightingale Health Plc – Managers’ transactions – 23 March 2021 9.30 a.m. (Finnish time)

Nightingale Health Plc – Managers' Transactions


Person subject to the notification requirement

Name: Suna, Teemu

Position: Chief Executive Officer

Issuer: Nightingale Health Oyj



Reference number: 743700WUIPC24LVMLO66_20210322195232_2


Transaction date: 2021-03-22


Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 562 Unit price: 4.735 EUR

(2): Volume: 642 Unit price: 4.735 EUR

(3): Volume: 317 Unit price: 4.735 EUR

(4): Volume: 1,791 Unit price: 4.735 EUR

(5): Volume: 150 Unit price: 4.735 EUR

(6): Volume: 1,071 Unit price: 4.735 EUR

(7): Volume: 150 Unit price: 4.735 EUR

(8): Volume: 186 Unit price: 4.735 EUR

(9): Volume: 410 Unit price: 4.735 EUR

Aggregated transactions

(9): Volume: 5,279 Volume weighted average price: 4.735 EUR

For further information, please contact:

Teemu Suna, CEO, tel. +358 20 730 1810

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals’ preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.